Advanced artificial intelligence combined with SERS platforms for diagnosis and therapeutic effects of cancer in clinical applications
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026-03 · 348 · 127053
DOI: 10.1016/j.saa.2025.127053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026-03. Verfasst von Rana Zaki Abdul Bari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Photonics and Biophotonics, College of Physics and Optoelectronic Engineering, Key Laboratory of Optoelectronic Devices an…. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Neoplasms, Artificial Intelligence. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 164 Literaturangaben. Gefördert von: Lietuvos Mokslo Taryba.
Abstract (Originalsprache)
Surface-Enhanced Raman Spectroscopy (SERS) has become a valuable way to detect small amounts of molecules due to its high sensitivity. Nonetheless, applying it in the clinic has been slow because of issues with the spectrum's complexity, background noise, and differences in biological samples. Integrating Artificial Intelligence (AI) into SERS has made its use for diagnostics much better by allowing automation of spectral preprocessing, noise removal, key information extraction, and accurate classification. Traditional machine learning (ML) and advanced deep learning (DL) AI algorithms can effectively interpret complex SERS data and recognize the biomarkers specific to different diseases in non-invasive samples such as serum, saliva, urine, breath condensates, and exosomes. AI-SERS technology provides a quick, scalable way to find cancer at an early stage, classify the type of cancer, and track the effects of therapy, matching the goals of precision oncology. It clearly explains the fundamentals of SERS, AI-based techniques to signal analysis and how the two are employed together in oncology. We describe new progress toward diagnosing many cancers, assessing outcomes, and tracking how patients react to therapy. In particular, the review presents the use of AI-enhanced SERS platforms for cancers of different types, such as breast cancer (BC), lung cancer (LC), prostate cancer (PCa), skin cancer, oral cancer, gastrointestinal cancers, colorectal cancer (CRC), pancreatic cancer (PaC), and ovarian cancer (OvCa). We also discuss how these platforms are being used for early diagnosis, monitoring treatment effects, and predicting the possibility of the disease returning. Ultimately, we discuss how key translational challenges like data standardization, the ability to explain models, and the need for approval by authorities must be dealt with before AI-SERS can be used routinely in clinical oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Photonics and Biophotonics, College of Physics and Optoelectronic Engineering, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, Shenzhen Un…
- Institute of Materials Science, Kaunas University of Technology, K. Baršausko St. 59, LT-51423 Kaunas, Lithuania. Electronic address: usman@xzhmu.edu.cn.
- Guangdong Key Laboratory of Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, PR China.
- Department of Chemistry, University of Agriculture Faisalabad, Faisalabad 38000, Pakistan.
- Institute of Materials Science, Kaunas University of Technology, K. Baršausko St. 59, LT-51423 Kaunas, Lithuania. Electronic address: Sigitas.Tamulevicius@ktu.lt.
- School of Medicine and Health, Harbin Institute of Technology, Harbin 150001, Heilongjiang, China. Electronic address: changshui@hotmail.com.
Förderung
- Lietuvos Mokslo Taryba
Zitieren
APA
Bari, R. Z. A., Usman, M., Huda, N. U., Javed, M. A., Tamulevičius, S., & Zhang, X. (2026). Advanced artificial intelligence combined with SERS platforms for diagnosis and therapeutic effects of cancer in clinical applications. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 348, 127053. https://doi.org/10.1016/j.saa.2025.127053
Vancouver
Bari RZA, Usman M, Huda NU, Javed MA, Tamulevičius S, Zhang X. Advanced artificial intelligence combined with SERS platforms for diagnosis and therapeutic effects of cancer in clinical applications. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026;348:127053. doi:10.1016/j.saa.2025.127053
BibTeX
@article{Bari2026,
author = {Bari, Rana Zaki Abdul and Usman, Muhammad and Huda, Noor Ul and Javed, Muhammad Abdullah and Tamulevičius, S and Zhang, Xiao},
title = {Advanced artificial intelligence combined with SERS platforms for diagnosis and therapeutic effects of cancer in clinical applications},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
volume = {348},
pages = {127053},
doi = {10.1016/j.saa.2025.127053}
}
EUVIMED